← All trials
NCT05424315
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2021
- Primary completion
- Apr 30, 2022
- Completion date
- Apr 30, 2022
- First posted
- Jun 21, 2022
- Last posted
- Jun 30, 2022
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Heart Institute, EgyptLead sponsor
- National Heart Institute, EgyptSponsor investigator
- Ain Shams UniversityCollaborator
- Ain Shams UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.